Docoh
Loading...
Sign up Log in

WBA Walgreens Boots Alliance

Walgreens Boots Alliance is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, and through its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling. Including equity method investments, WBA has a presence in more than 25 countries, employs more than 450,000 people and has more than 21,000 stores. WBA's purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. WBA is included in FORTUNE's 2020 list of the World's Most Admired Companies*, ranked first in the food and drugstore category. This is the 27th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list.

Company profile

Ticker
WBA
Exchange
NASDAQ
Website
www.walgreensbootsalliance.com
CEO
Stefano Pessina
Employees
Incorporated
Delaware
Location
Illinois
Fiscal year end
Aug 31
Sector
Retail Trade > Pharmacies and Drug Stores
Industry (SIC)
Retail - Drug Stores and Proprietary Stores
CVS Health • Rite Aid • Covetrus • 111 • Petmed Express • China Jo-Jo Drugstores • Dougherty's Pharmacy • Dragon Jade International • MedAvail • AiXin Life International ...
SEC CIK
0001618921
Corporate docs

WBA stock data

(
)

News

Pro users get this 30m faster
Unusual Options Activity Insight: Walgreens Boots Alliance
29 Jul 21
Shares of Walgreens Boots Alliance (NASDAQ:WBA) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $47.05.
Return on Capital Employed Overview: Walgreens Boots Alliance
29 Jul 21
After pulling data from Benzinga Pro it seems like during Q3, Walgreens Boots Alliance (NASDAQ:WBA) earned $1.04 billion, a 24.64% increase from the preceding quarter.
Walgreens And VillageMD Highlights Opening Of New Primary Care Practices In Indiana
23 Jul 21
Strategic partnership on track to open at least 600 primary care practices in more than 30 U.S. markets over next four years Walgreens Boots Alliance (NASDAQ:WBA) and VillageMD today announced plans to open
Return on Capital Employed Overview: Walgreens Boots Alliance
21 Jul 21
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
20 Jul 21

Press releases

Pro users get this 30m faster
Walgreens and VillageMD Expand to Northern Indiana, Opening New Full-Service Primary Care Practices This Year
23 Jul 21
Strategic partnership on track to open at least 600 primary care practices in more than 30 U.S. markets over next four years Walgreens Boots Alliance (NASDAQ:WBA) and VillageMD today announced plans to open new Village
Premera Blue Cross, Walgreens Community Vaccine Clinic Supports Health Equity Efforts in South King County
20 Jul 21
Tukwila, Wash, July 20, 2021 (GLOBE NEWSWIRE) -- As part of a shared commitment to ensuring equitable access to COVID-19 vaccines, Premera Blue Cross and Walgreens are hosting a community vaccine clinic in Tukwila. The
Walgreens Boots Alliance Increases Quarterly Dividend
14 Jul 21
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced that its board of directors has declared a quarterly dividend of 47.75 cents per share, an increase of 2.1 percent. The increased dividend is payable September
Walgreens and VillageMD to Open 29 Full-Service Primary Care Practices in Texas This Year
8 Jul 21
Walgreens Expands Same Day Prescription Delivery
8 Jul 21

Calendar

1 Jul 21
31 Jul 21
31 Aug 21

Financial summary

Financial statements Chart WBA financial data
Quarter (USD)
 May 21 Feb 21 Nov 20 Aug 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Aug 20 Aug 19 Aug 18 Aug 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Recent insider trades

WBA insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Jul 21 Murphy Dominic Phantom Stock Units Common Stock Grant Aquire A No No 46.88 533.276 25K 41,133.96
14 Jul 21 Skinner James A Phantom Stock Units Common Stock Grant Aquire A No No 46.88 533.276 25K 89,382
14 Jul 21 Jarrett Valerie B Phantom Stock Units Common Stock Grant Aquire A No No 46.88 533.276 25K 1,792.84
14 Jul 21 Brailer David J Phantom Stock Units Common Stock Grant Aquire A No No 46.88 639.932 30K 54,629.74
14 Jul 21 Lederer John Anthony Phantom Stock Units Common Stock Grant Aquire A No No 46.88 533.276 25K 31,014.99
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

WBA institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

72.4% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 1266 1159 +9.2%
Opened positions 193 174 +10.9%
Closed positions 86 123 -30.1%
Increased positions 420 356 +18.0%
Reduced positions 482 490 -1.6%
13F shares
 Current Prev Q Change
Total value 32.29B 24.95B +29.4%
Total shares 626.63M 623.86M +0.4%
Total puts 13.78M 14.23M -3.2%
Total calls 11.47M 10.85M +5.7%
Total put/call ratio 1.2 1.3 -8.4%
Largest owners
 Shares Value Change
Alliance Sante Participations 144.79M $5.84B 0.0%
Vanguard 58.32M $3.2B +0.4%
BLK Blackrock 56.87M $3.12B +13.8%
STT State Street 44.86M $2.46B -4.2%
Capital World Investors 21.39M $1.17B +26.0%
FMR 15.92M $874.2M -5.8%
Geode Capital Management 11.42M $624.92M +1.8%
Aristotle Capital Management 9.42M $515.13M +10.2%
NTRS Northern Trust 8.86M $486.26M -1.7%
BK Bank Of New York Mellon 8.31M $456.24M -0.0%
Largest transactions
 Shares Bought/sold Change
Norges Bank 0 -7.84M EXIT
BLK Blackrock 56.87M +6.91M +13.8%
Capital World Investors 21.39M +4.42M +26.0%
Caisse De Depot Et Placement Du Quebec 5.33M -2.94M -35.6%
Susquehanna International 2.65M -2.93M -52.5%
Shapiro Capital Management 2.58M +2.58M NEW
Burgundy Asset Management 3.73K -2.46M -99.8%
Cullen Capital Management 2.46M +2.02M +454.2%
Eminence Capital 2.01M +2.01M NEW
STT State Street 44.86M -1.98M -4.2%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Cigna
Management Discussion
  • The Company's United States segment includes the Walgreens business which includes the operations of retail drugstores, health and wellness services, and mail and central specialty pharmacy services, and its equity method investment in AmerisourceBergen. Sales for the segment are principally derived from the sale of prescription drugs and a wide assortment of retail products, including health and wellness, beauty, personal care and consumables and general merchandise.
  • WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
  • 1See “--Non-GAAP Measures” below for a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP and related disclosures.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: advance, ago, Bd, beneficially, Cnty, Cobb, convenient, counter, deconsolidated, deconsolidation, Durham, earliest, employer, extinguishment, growing, HC, investee, LLC, lost, meaningful, Montgomery, NM, phased, prepayment, rebound, reopen, reopening, revaluing, slight, slower, Tarrant, tender
Removed: account, closely, complex, cybersecurity, decreasing, distancing, economy, footfall, forecasting, globally, governance, materialize, modification, negatively, participate, personnel, positioning, privacy, rapidly, realize, reflected, retain, ruling, scope, social, tariff, vandalism, weaker
From filing 10-Q 2021 Q3

Financial reports

View all
10-Q
2021 Q3
Quarterly report
1 Jul 21
10-Q
2021 Q2
Quarterly report
31 Mar 21
10-Q
2021 Q1
Quarterly report
7 Jan 21
10-K
2020 FY
Annual report
15 Oct 20
10-Q
2020 Q3
Quarterly report
9 Jul 20
10-Q
2020 Q2
Quarterly report
2 Apr 20
10-Q
2020 Q1
Quarterly report
8 Jan 20
10-K
2019 FY
Annual report
28 Oct 19
10-Q
2019 Q3
Quarterly report
27 Jun 19
10-Q
2018 Q2
Quarterly report
2 Apr 19

Current reports

View all
8-K
Departure of Directors or Certain Officers
20 Jul 21
8-K
Walgreens Boots Alliance Fiscal 2021 Third Quarter Results Exceed Expectations
1 Jul 21
8-K
Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen
4 Jun 21
8-K
Departure of Directors or Certain Officers
20 May 21
8-K
Departure of Directors or Certain Officers
14 May 21
8-K
Departure of Directors or Certain Officers
30 Apr 21
8-K
Departure of Directors or Certain Officers
26 Apr 21
8-K
Walgreens Boots Alliance Announces the Pricing Terms of its Tender Offer for Certain Outstanding Debt Securities
23 Apr 21
8-K
Walgreens Boots Alliance Announces the Early Results and Upsizing of its Tender Offer for Certain Outstanding Debt Securities
23 Apr 21
8-K
Walgreens Boots Alliance Commences Tender Offer to Purchase Certain Outstanding Debt Securities
9 Apr 21

Registration and prospectus

View all
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Feb 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Feb 21
S-8
Registration of securities for employees
5 Feb 21
25-NSE
Exchange delisting
19 Oct 20
424B5
Prospectus supplement for primary offering
14 Apr 20
FWP
Free writing prospectus
13 Apr 20
424B5
Prospectus supplement for primary offering
12 Apr 20
25
Voluntary exchange delisting
21 Dec 18
8-A12B
Registration of securities on exchange
21 Dec 18
S-3ASR
Automatic shelf registration
20 Dec 18

Proxies

View all
DEFA14A
Additional proxy soliciting materials
14 Jan 21
PX14A6G
Letter to shareholders
17 Dec 20
DEFA14A
Additional proxy soliciting materials
8 Dec 20
DEF 14A
Definitive proxy
8 Dec 20
DEFA14A
Additional proxy soliciting materials
3 Jan 20
DEFA14A
Additional proxy soliciting materials
10 Dec 19
DEF 14A
Definitive proxy
10 Dec 19
PX14A6G
Letter to shareholders
14 Dec 18
DEFA14A
Additional proxy soliciting materials
6 Dec 18
DEF 14A
Definitive proxy
6 Dec 18

Other

View all
UPLOAD
Letter from SEC
8 Apr 18
CORRESP
Correspondence with SEC
4 Apr 18
NO ACT
No action letter
9 Oct 17
UPLOAD
Letter from SEC
20 Apr 17
CORRESP
Correspondence with SEC
11 Apr 17
CORRESP
Correspondence with SEC
23 Mar 17
UPLOAD
Letter from SEC
22 Feb 17
NO ACT
No action letter
21 Nov 16
NO ACT
No action letter
2 Nov 16
NO ACT
No action letter
11 Oct 16

Ownership

View all
3
Walgreens Boots Alliance / Manmohan Mahajan ownership change
26 Jul 21
4
Walgreens Boots Alliance / VALERIE B JARRETT ownership change
16 Jul 21
4
Walgreens Boots Alliance / DAVID J BRAILER ownership change
16 Jul 21
4
Walgreens Boots Alliance / John Anthony Lederer ownership change
16 Jul 21
4
Walgreens Boots Alliance / JAMES A SKINNER ownership change
16 Jul 21
4
Walgreens Boots Alliance / Dominic Murphy ownership change
16 Jul 21
4
Walgreens Boots Alliance / James Kehoe ownership change
3 Jun 21
SC 13D/A
AMERISOURCEBERGEN / Walgreens Boots Alliance ownership change
3 Jun 21
4
Walgreens Boots Alliance / Heather Brianne Dixon ownership change
4 May 21
4
Walgreens Boots Alliance / VALERIE B JARRETT ownership change
26 Apr 21

Patents

View all
APP
Utility
Cosmetic Preservative System
15 Jul 21
According to the present invention there is provided a cosmetic composition comprising a cosmetically acceptable carrier and a preservative system, wherein the preservative system comprises: (i) an antimicrobial agent; (ii) a chelating agent comprising ethylenediamine tetraacetic acid (EDTA) or a derivative thereof; and (iii) an antimicrobial booster agent selected from the group consisting of ethylhexylglycerin, caprylyl glycol, hydroxy acetophenone, caprylhydroxamic acid, phenethyl alcohol, p-anisic acid, glyceryl caprylate, levulinic acid, sodium levulinate, propanediol, hexanediol, pentylene glycol, capryloyl glycine, methylpropanediol, phenylpropanol, sodium anisate, and combinations thereof, wherein the antimicrobial agent is present in an amount of from about 0.001% to about 1% by weight of the composition.
APP
Utility
Cosmetic Skincare Compositions
1 Jul 21
According to the present invention there is provided a cosmetic composition comprising: (i) a salicylic acid compound; (ii) monoammonium glycyrrhizate; and (iii) a polyphenolic antioxidant agent.
APP
Utility
Cosmetic Cleansing Compositions
1 Jul 21
According to the present invention there is provided a cosmetic composition comprising a cosmetically acceptable carrier and a surfactant system consisting of: (i) an anionic surfactant; (ii) an amphoteric surfactant; and (iii) a non-ionic surfactant, wherein the anionic surfactant is present in an amount of from about 0.5% to about 25% by weight of the surfactant system, wherein the amphoteric surfactant is present in an amount of from about 0.5% to about 50% by weight of the surfactant system, wherein the non-ionic surfactant is present in an amount of from about 0.5% to about 45% (e.g. 43%) by weight of the surfactant system, and wherein the total amount of the surfactant system present in the cosmetic composition is from about 1.5% to about 25% by weight of the composition.
APP
Utility
Cosmetic Compositions
3 Jun 21
Inventors: Jake Thomas Hicks, Marco Demurtas, Christopher John Elms, Paul James Tomlinson, Michael David Bell
APP
Utility
Concentrated Cosmetic Composition
18 Mar 21
According to the present invention there is provided an aqueous concentrated cosmetic composition comprising at least 20% water, at least 4.5% by weight of the composition of humectant, at least 8% of the composition of a peptide and high levels of a skin benefit active(s).

Transcripts

View all
2021 Q3
Earnings call transcript
1 Jul 21
2021 Q2
Earnings call transcript
31 Mar 21
2021 Q1
Earnings call transcript
7 Jan 21
2020 Q4
Earnings call transcript
15 Oct 20
2020 Q3
Earnings call transcript
9 Jul 20
2020 Q2
Earnings call transcript
2 Apr 20
2020 Q1
Earnings call transcript
8 Jan 20
2019 Q4
Earnings call transcript
28 Oct 19
2019 Q3
Earnings call transcript
27 Jun 19
2019 Q2
Earnings call transcript
2 Apr 19

Reddit threads

View all